获得性青少年起病特发性双眼白内障患者中脑腱黄瘤病的患病率
该研究为脑腱黄瘤病患病率研究的中期分析,在美国26个站点纳入2至21岁诊断为特发性双眼白内障的患者170例,检测血浆胆甾烷醇和尿胆汁醇,必要时行CYP27A1基因检测。3例(1.8%)新诊断脑腱黄瘤病,约为普通人群估计患病率(每10万人3至5例)的500倍。作者认为青少年起病特发性双眼白内障或可作为脑腱黄瘤病的筛查标志物。
要点
- 170例特发性双眼白内障患者中3例(1.8%)经生化和基因确诊新诊断脑腱黄瘤病。
- 脑腱黄瘤病患者白内障诊断平均年龄12岁(范围8-16岁)。
- 1.8%约为普通人群估计患病率(每10万人3至5例)的500倍。
核心结论
- 截至分析时,本研究中1.8%的患者被诊断为脑腱黄瘤病,约为目前估计的普通人群患病率(每10万人3至5例)的500倍。
- 这些数据提示青少年起病特发性双眼白内障或可作为脑腱黄瘤病的筛查标志物,眼科医生可在促进该病早期识别中发挥重要作用。
研究设计与样本
- 脑腱黄瘤病患病率研究的中期分析,于2015年11月至2017年6月在美国26个活跃站点开展。
- 纳入2至21岁诊断为特发性双眼白内障的患者,通过回顾性病历复习或站点诊疗中识别,数据于2017年7月至2018年10月分析。
- 检测血浆胆甾烷醇水平,并可选做尿胆汁醇筛查;血浆胆甾烷醇浓度≥0.4 mg/dL或尿胆汁醇阳性时行CYP27A1基因检测以确诊。
主要发现
- 170例受检患者中88例(51.8%)为男性,中位年龄10岁(范围2-49岁)。
- 3例患者(1.8%)经生化和基因确诊为新诊断脑腱黄瘤病:血浆胆甾烷醇水平大于1.0 mg/dL、尿胆汁醇阳性、CYP27A1存在致病突变。
- 脑腱黄瘤病患者白内障诊断平均年龄为12岁(范围8-16岁)。
- 报告的症状包括步态或平衡异常(n=3)、学习障碍(n=2)、认知下降(n=2)、癫痫发作(n=2)、频繁骨折(n=2)和慢性腹泻(n=1)。
关键数值与推荐
- 血浆胆甾烷醇浓度≥0.4 mg/dL或尿胆汁醇阳性时行CYP27A1基因检测以确诊脑腱黄瘤病。
- 确诊脑腱黄瘤病需血浆胆甾烷醇水平大于1.0 mg/dL、尿胆汁醇阳性及CYP27A1致病突变。
- 普通人群脑腱黄瘤病估计患病率为每10万人3至5例。
临床怎么用
- 作者认为青少年起病特发性双眼白内障或可作为脑腱黄瘤病的筛查标志物。
- 作者认为眼科医生可在促进该病早期识别中发挥重要作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive bile acid synthesis disorder caused by mutations in CYP27A1, the gene encoding sterol 27-hydroxylase, which results in elevated levels of plasma cholestanol and urinary bile alcohols. Clinical symptoms and signs may include early-onset chronic diarrhea, juvenile-onset bilateral cataracts, cholestatic jaundice, tendon xanthomas, and progressive neurological deterioration. Although initiation of treatment at a young age can prevent disease complications, diagnosis often occurs after the onset of permanent neurologic damage. Strategies are needed to facilitate early diagnosis. OBJECTIVE: To evaluate the prevalence of CTX in a patient population diagnosed with early-onset idiopathic bilateral cataracts. DESIGN, SETTING, AND PARTICIPANTS: This interim analysis of the Cerebrotendinous Xanthomatosis Prevalence Study was conducted in 26 active US sites from November 2015 to June 2017. The study included patients diagnosed as having idiopathic bilateral cataracts from ages 2 to 21 years. Potentially eligible study participants were identified through retrospective medical record review or on receiving care for cataracts at an active site. Data were analyzed from July 2017 to October 2018. MAIN OUTCOMES AND MEASURES: Measurement of plasma cholestanol levels and optional urine bile alcohol screening were performed. A plasma cholestanol concentration of 0.4 mg/dL or greater or a positive urine bile alcohol result prompted CYP27A1 genetic testing to confirm the diagnosis of CTX. RESULTS: Of 170 tested patients, 88 (51.8%) were male, and the median (range) age was 10 (2-49) years. A total of 3 patients (1.8%) had biochemical and genetic confirmation of newly diagnosed CTX (plasma cholestanol level greater than 1.0 mg/dL, positive urine bile alcohol result, and disease-causative mutations in CYP27A1). The mean (range) age at cataract diagnosis for patients with CTX was 12 (8-16) years. Reported symptoms included abnormal gait or balance (n = 3), learning disability (n = 2), cognitive decline (n = 2), seizures (n = 2), frequent bone fractures (n = 2), and chronic diarrhea (n = 1). CONCLUSIONS AND RELEVANCE: To date, 1.8% of patients in this study were diagnosed as having CTX, which is approximately 500-fold the currently estimated prevalence of CTX in the general population (3 to 5 per 100 000). These data suggest that juvenile-onset idiopathic bilateral cataracts may be useful as a screening marker for CTX and that ophthalmologists can play an important role in facilitating early identification of this condition.
引用
- Freedman SF, Brennand C, Chiang J, et al. Prevalence of Cerebrotendinous Xanthomatosis Among Patients Diagnosed With Acquired Juvenile-Onset Idiopathic Bilateral Cataracts. JAMA Ophthalmol. 2019. PMID: 31536098. doi:10.1001/jamaophthalmol.2019.3639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。